| Sector |
Other
|
Compare with Sector peers |
| Industry |
Business Support
|
Compare with Industry peers |
| Website | http://www.vantabio.com | |
| Market Cap | 39.89 Cr. | |
| Enterprise Value(EV) | 64.49 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -10.27 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 61.85 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 27.75 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 2.28 | Calculated using Price: 63.19 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.63 Cr. | 6,312,000 Shares |
| FaceValue | 10 | |
| About Vanta Bioscience Ltd. | ||
| The company is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition they also provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation. | ||
| 1 Day |
|
-4.98% |
| 1 Week |
|
-1.27% |
| 1 Month |
|
-13.91% |
| 3 Month |
|
+8.95% |
| 6 Month |
|
+43.61% |
| 1 Year |
|
+10.16% |
| 2 Year |
|
-51.39% |
| 5 Year |
|
-66.74% |
| 10 Year |
|
| 5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 3.14 | 4.43 | 1.89 | 0.56 | -50.31 | |
| Return on Capital Employed (%) | 7.87 | 8.62 | 5.42 | 4 | -6.1 | |
| Return on Assets (%) | 1.78 | 2.31 | 0.76 | 0.18 | -12.57 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 22 | 23 | 24 | 24 | 18 | 17 | |
| Non Curr. Liab. | 13 | 14 | 29 | 38 | 48 | 47 | |
| Curr. Liab. | 3 | 10 | 15 | 14 | 18 | 18 | |
| Minority Int. | 1 | 1 | 2 | 5 | 1 | 2 | |
| Equity & Liab. | 39 | 49 | 70 | 81 | 85 | 85 | |
| Non Curr. Assets | 22 | 29 | 50 | 67 | 69 | 69 | |
| Curr. Assets | 17 | 20 | 20 | 15 | 15 | 15 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 39 | 49 | 70 | 81 | 85 | 85 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 12 | 14 | 10 | 10 | 6 | |
| Other Income | 0 | 0 | 0 | 0 | 1 | |
| Total Income | 12 | 14 | 10 | 10 | 7 | |
| Total Expenditure | -9 | -9 | -6 | -6 | -9 | |
| PBIDT | 4 | 4 | 4 | 4 | -2 | |
| Interest | -2 | -2 | -2 | -2 | -6 | |
| Depreciation | -1 | -1 | -1 | -1 | -3 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | |
| Exceptional Items | ||||||
| PAT | 1 | 1 | 0 | 0 | -10 | |
| Minority Interest | 0 | 0 | 4 | |||
| Share Associate | ||||||
| Other Related Items | ||||||
| Consolidated Net Profit | 1 | 1 | 0 | 0 | -6 | |
| Adjusted EPS | 1 | 2 | 1 | 0 | -10 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | 2 | 7 | 5 | -1 | |
| Cash Fr. Inv. | -6 | -7 | -22 | -17 | -6 | |
| Cash Fr. Finan. | 10 | 2 | 18 | 9 | 6 | |
| Net Change | 3 | -3 | 2 | -2 | 0 | |
| Cash & Cash Eqvt | 3 | 0 | 3 | 0 | 0 |
|
Tue, 02 Apr 2024
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Receipt of order worth Rs. 1.2 Cr for technical studies |
|
Mon, 01 Apr 2024
Appointment of Company Secretary and Compliance Officer Appointment of CS and Compliance Officer w.e.f 01.04.2024 |
|
Sat, 30 Mar 2024
Closure of Trading Window Closure of Trading Window |
| Fri, 19 Apr 2024 |
Opening at High
|
Opening at Low
|
Closing Below Previous Low
|
Opening at High for 2 Days
|
High Decrease in 1 Month
|
